Fig. 4From: A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in UgandaForest plot of randomised controlled trials of second-stage HAT treatment comparing nifutimox-eflonithine vs eflornithineBack to article page